Infermedica

The firm provides a B2B Medical Guidance Platform for healthcare organizations, including insurers like Allianz and Cigna, providers, and telemedicine companies. Revenue is generated by offering its technology as white-label, API-first solutions that integrate into clients' existing systems, such as patient portals and mobile apps. This business model is designed to help clients reduce costs, increase efficiency, and improve patient flow by guiding individuals to the appropriate level of care. As of January 2022, Infermedica has raised a total of $45 million over several funding rounds, including a $30 million Series B round led by One Peak. These funds are earmarked for further development of the platform and global expansion.

Infermedica's core technology is an AI engine built upon a vast medical knowledge base, developed with over 140,000 hours of physician input. The platform consists of several modules that cover the primary care journey. The "Triage" module is a sophisticated symptom checker that uses a dynamic, AI-driven interview to analyze a user's condition and suggest the right level of care, from self-care to an emergency room visit. The "Intake" module automates patient information gathering before a consultation, aiming to streamline appointment workflows and reduce administrative work for clinicians. A "Follow-Up" module is also in development. The system's AI leverages natural language processing to make medical information more understandable to patients and has achieved a 95% accuracy rate for its engine. The platform is utilized in over 30 countries and is available in more than 20 languages.